文献速递复苏、休克与脓毒症

心脏骤停期间静脉与骨内给药的系统评价

Intravenous vs. intraosseous administration of drugs during cardiac arrest: A systematic review.
PubMed 文献 · Resuscitation · 2020-03-03
一句话结论成人院外心脏骤停中,四项观察性研究汇总结果倾向于静脉通路,证据确定性极低;两项随机试验的亚组分析未发现通路与药物间有统计学显著交互作用,但检验效能不足。

该系统评价按PRISMA进行并于PROSPERO注册,检索Medline、Embase和EBM Reviews(2019年12月17日),纳入比较心脏骤停时静脉与骨内给药的观察性研究和随机试验。共纳入6项观察性研究和2项随机试验,均为成人院外心脏骤停,无新生儿或儿科研究。观察性研究的偏倚风险总体评为极严重或严重,主要来源为混杂和选择偏倚;排除极严重偏倚研究后的Meta分析显示所有结局均倾向于静脉通路,GRADE证据确定性为极低。两项随机试验的亚组分析未发现通路与研究药物对结局有统计学显著交互作用,但试验检验效能不足。

要点

  • 纳入6项观察性研究和2项随机试验,全部为成人院外心脏骤停,无新生儿或儿科数据。
  • 观察性研究偏倚风险总体为极严重或严重,主要来源是混杂和选择偏倚。
  • 排除极严重偏倚研究后的Meta分析显示所有结局均倾向于静脉通路,GRADE证据确定性为极低。
  • 两项随机试验亚组分析未发现通路与研究药物对结局有统计学显著交互作用,但试验检验效能不足。

适用人群与场景

  • 成人院外心脏骤停患者(纳入的6项观察性研究和2项随机试验均为此人群)。
  • 未检索到新生儿或儿科心脏骤停患者中比较静脉与骨内给药的研究。

研究设计与关键结果

  • 系统评价按PRISMA进行并在PROSPERO注册,检索Medline、Embase和Evidence-Based Medicine Reviews(2019年12月17日),由两名研究者独立筛选文献、提取数据并评估偏倚风险。
  • 共纳入6项观察性研究和2项随机试验,均为成人院外心脏骤停患者;无新生儿或儿科研究。
  • 观察性研究的偏倚风险总体评为极严重或严重,主要偏倚来源为混杂和选择偏倚。
  • 排除极严重偏倚研究后的Meta分析显示所有结局均倾向于静脉通路,GRADE证据确定性为极低。
  • 两项随机试验的亚组分析未发现通路与研究药物对结局有统计学显著交互作用,但试验检验效能不足。

证据类型、等级与局限

  • 证据类型:系统评价(含6项观察性研究和2项随机试验),采用GRADE评估证据确定性。
  • GRADE证据确定性:极低。
  • 局限:观察性研究的偏倚风险总体为极严重或严重,主要来源为混杂和选择偏倚;两项随机试验检验效能不足,无法评估通路与药物的交互作用。

对床旁实践的改变

  • 作者认为,基于四项观察性研究的汇总结果,静脉通路倾向于更优,但证据确定性为极低。
  • 两项随机试验的亚组分析未发现通路与研究药物对结局有统计学显著交互作用,但试验检验效能不足。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

AIM: To perform a systematic review of the literature on intravenous (IV) vs. intraosseous (IO) administration of drugs during cardiac arrest in order to inform an update of international guidelines.

METHODS: The review was performed according to PRISMA guidelines and registered on PROSPERO. Medline, Embase and Evidence-Based Medicine Reviews were searched on December 17, 2019 for studies comparing IV to IO administration of drugs. The population included neonatal, paediatric, and adult patients with cardiac arrest. Two investigators reviewed each search for study relevance, extracted data, and assessed the risk of bias of individual studies. Meta-analyses were performed for studies without a critical risk of bias. Certainty of evidence was evaluated using GRADE.

RESULTS: We included six observational studies comparing IV to IO administration of drugs and two randomized trials assessing the effect of specific drugs in subgroups related to IV vs. IO administration. All studies included adult out-of-hospital cardiac arrest patients. No studies were identified in neonatal or paediatric patients. The risk of bias for the observational studies was overall assessed as critical or serious, with confounding and selection bias being the primary sources of bias. The meta-analyses excluding studies with a critical risk of bias favoured IV access for all outcomes. Using GRADE, the certainty of evidence was judged at very low. Subgroup analyses of the two randomized trials demonstrated no statistically significant interactions between the route of access and study drugs on outcomes. However, these trials were underpowered to assess such interactions.

CONCLUSIONS: We identified a limited number of studies comparing IV vs. IO administration of drugs during cardiac arrest. Pooled results from four observational studies favoured IV access with very low certainty of evidence. From the subgroup analyses of two randomized clinical trials, there was no statistically significant interaction between the route of access and study drug on outcomes.

来源:Resuscitation,查看原文。版权归原作者所有。

参考来源

  1. Granfeldt A, Avis SR, Lind PC, et al. Intravenous vs. intraosseous administration of drugs during cardiac arrest: A systematic review. Resuscitation. 2020. PMID: 32142750. doi:10.1016/j.resuscitation.2020.02.025

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。